JP Stock MarketDetailed Quotes

2929 Pharma Foods International

Watchlist

957
-8-0.83%

20min DelayMarket Closed Nov 1 15:00 JST

27.83BMarket Cap8.49P/E (Static)

Pharma Foods International Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jul 31, 2024

(Q4)Jul 31, 2024

(Q3)Apr 30, 2024

(Q2)Jan 31, 2024

(Q1)Oct 31, 2023

(FY)Jul 31, 2023

(Q4)Jul 31, 2023

(Q3)Apr 30, 2023

(Q2)Jan 31, 2023

(Q1)Oct 31, 2022

Total revenue

-9.37%62.15B

-6.63%14.98B

-10.76%15.52B

-14.37%15.51B

-5.21%16.14B

13.94%68.57B

-0.59%16.04B

14.19%17.39B

11.71%18.11B

35.09%17.03B

Cost of revenue

0.77%13.4B

15.00%3.53B

-4.41%3.32B

-11.97%3.13B

6.87%3.42B

10.07%13.29B

-5.63%3.07B

14.10%3.47B

-8.17%3.55B

67.05%3.2B

Gross profit

-11.81%48.75B

-11.74%11.45B

-12.36%12.2B

-14.95%12.38B

-8.01%12.72B

14.91%55.28B

0.68%12.97B

14.22%13.92B

17.92%14.56B

29.36%13.83B

Operating expense

-15.55%43.64B

-12.69%9.6B

-8.17%10.47B

-13.59%11.45B

-24.37%12.11B

9.87%51.67B

-13.66%11B

-14.21%11.4B

11.45%13.25B

75.83%16.02B

Selling and administrative expenses

-18.55%34.99B

-15.41%7.42B

-9.85%8.42B

-16.46%9.21B

-28.11%9.94B

9.71%42.96B

-16.73%8.77B

-18.03%9.34B

13.13%11.03B

84.75%13.82B

-Selling and marketing expense

-20.78%30.79B

-17.24%6.39B

-10.86%7.41B

-18.52%8.18B

-31.15%8.81B

8.72%38.87B

-19.49%7.72B

-21.20%8.31B

12.96%10.04B

90.19%12.8B

-General and administrative expense

2.61%4.2B

-1.99%1.03B

-1.74%1.01B

4.33%1.04B

10.11%1.12B

20.05%4.1B

11.19%1.05B

21.13%1.03B

14.95%992M

35.87%1.02B

Research and development costs

16.43%978M

13.28%273M

19.89%223M

-0.97%205M

34.47%277M

9.66%840M

-17.18%241M

12.73%186M

25.45%207M

42.07%206M

Depreciation and amortization

37.50%99M

0.00%18M

110.53%40M

35.29%23M

41.18%72M

5.88%18M

38.46%18M

72.73%19M

70.00%17M

-Depreciation

--0

-Amortization

37.50%99M

0.00%18M

110.53%40M

35.29%23M

41.18%72M

5.88%18M

38.46%18M

72.73%19M

70.00%17M

Other operating expenses

-2.90%7.57B

-3.87%1.89B

-2.59%1.81B

-0.25%1.99B

-4.91%1.88B

10.57%7.79B

3.80%1.97B

8.23%1.86B

1.58%2B

33.97%1.98B

Operating profit

41.64%5.12B

-6.43%1.85B

-31.31%1.73B

-28.70%934M

127.50%603M

233.83%3.61B

1,234.46%1.98B

328.88%2.52B

186.03%1.31B

-239.06%-2.19B

Net non-operating interest income (expenses)

-29.79%-61M

-63.64%-18M

-23.08%-16M

-18.18%-13M

-16.67%-14M

-95.83%-47M

-57.14%-11M

-160.00%-13M

-10.00%-11M

-500.00%-12M

Non-operating interest income

0.00%1M

--0

0.00%1M

--0

-50.00%1M

--0

--1M

-700.00%-6M

--6M

Non-operating interest expense

29.17%62M

63.64%18M

21.43%17M

160.00%13M

-22.22%14M

84.62%48M

37.50%11M

180.00%14M

-54.55%5M

800.00%18M

Net investment income

-5.88%32M

-58.33%10M

266.67%5M

1,000.00%11M

-50.00%6M

-53.42%34M

20.00%24M

-110.00%-3M

-93.75%1M

71.43%12M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

-90.63%-122M

-140.74%-130M

10M

-2M

-6,300.00%-64M

-5,300.00%-54M

-10M

Income from associates and other participating interests

57.32%-35M

66.67%-7M

-21.74%-28M

103.85%1M

91.67%-1M

-1,740.00%-82M

-200.00%-21M

-483.33%-23M

-620.00%-26M

-1,300.00%-12M

Special income (charges)

-5,150.00%-101M

-101M

-98.74%2M

Less:Other special charges

5,150.00%101M

----

97.40%-2M

--0

----

Other non-operating income (expenses)

133.71%208M

387.80%200M

-157.89%-11M

100.00%6M

-50.00%13M

-31.01%89M

20.59%41M

-53.66%19M

-85.00%3M

-23.53%26M

Income before tax

42.12%5.03B

-8.07%1.8B

-32.21%1.69B

-26.10%937M

127.75%605M

148.91%3.54B

638.87%1.96B

342.80%2.5B

160.37%1.27B

-228.31%-2.18B

Income tax

295.67%1.83B

935.19%451M

17.54%603M

25.97%456M

188.58%318M

-74.29%462M

-115.21%-54M

-37.21%513M

129.11%362M

-176.87%-359M

Net income

4.06%3.21B

-32.99%1.35B

-45.11%1.09B

-46.74%482M

115.71%286M

923.53%3.08B

2,336.67%2.01B

207.43%1.98B

174.24%905M

-247.85%-1.82B

Net income continuous operations

4.09%3.21B

-32.95%1.35B

-45.08%1.09B

-46.91%481M

115.76%287M

923.53%3.08B

2,335.56%2.01B

207.48%1.98B

175.38%906M

-247.81%-1.82B

Noncontrolling interests

-1M

Net income attributable to the company

4.02%3.21B

-32.99%1.35B

-45.11%1.09B

-46.80%482M

115.71%286M

923.80%3.08B

2,336.67%2.01B

207.43%1.98B

174.55%906M

-247.85%-1.82B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

4.02%3.21B

-32.99%1.35B

-45.11%1.09B

-46.80%482M

115.71%286M

923.80%3.08B

2,336.67%2.01B

207.43%1.98B

174.55%906M

-247.85%-1.82B

Gross dividend payment

Basic earnings per share

5.63%112.71

-31.55%47.71

-44.16%38.32

-46.28%16.74

115.83%9.94

927.77%106.7

2,348.39%69.7

207.81%68.62

173.09%31.16

-247.89%-62.78

Diluted earnings per share

5.63%112.71

-31.55%47.71

-44.16%38.32

-46.28%16.74

115.83%9.94

927.77%106.7

2,347.54%69.7

207.73%68.62

173.09%31.16

-247.96%-62.78

Dividend per share

13.64%25

25.00%15

0.00%10

10.00%22

20.00%12

0.00%10

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Jul 31, 2024	(Q4)Jul 31, 2024	(Q3)Apr 30, 2024	(Q2)Jan 31, 2024	(Q1)Oct 31, 2023	(FY)Jul 31, 2023	(Q4)Jul 31, 2023	(Q3)Apr 30, 2023	(Q2)Jan 31, 2023	(Q1)Oct 31, 2022
Total revenue	-9.37%62.15B	-6.63%14.98B	-10.76%15.52B	-14.37%15.51B	-5.21%16.14B	13.94%68.57B	-0.59%16.04B	14.19%17.39B	11.71%18.11B	35.09%17.03B
Cost of revenue	0.77%13.4B	15.00%3.53B	-4.41%3.32B	-11.97%3.13B	6.87%3.42B	10.07%13.29B	-5.63%3.07B	14.10%3.47B	-8.17%3.55B	67.05%3.2B
Gross profit	-11.81%48.75B	-11.74%11.45B	-12.36%12.2B	-14.95%12.38B	-8.01%12.72B	14.91%55.28B	0.68%12.97B	14.22%13.92B	17.92%14.56B	29.36%13.83B
Operating expense	-15.55%43.64B	-12.69%9.6B	-8.17%10.47B	-13.59%11.45B	-24.37%12.11B	9.87%51.67B	-13.66%11B	-14.21%11.4B	11.45%13.25B	75.83%16.02B
Selling and administrative expenses	-18.55%34.99B	-15.41%7.42B	-9.85%8.42B	-16.46%9.21B	-28.11%9.94B	9.71%42.96B	-16.73%8.77B	-18.03%9.34B	13.13%11.03B	84.75%13.82B
-Selling and marketing expense	-20.78%30.79B	-17.24%6.39B	-10.86%7.41B	-18.52%8.18B	-31.15%8.81B	8.72%38.87B	-19.49%7.72B	-21.20%8.31B	12.96%10.04B	90.19%12.8B
-General and administrative expense	2.61%4.2B	-1.99%1.03B	-1.74%1.01B	4.33%1.04B	10.11%1.12B	20.05%4.1B	11.19%1.05B	21.13%1.03B	14.95%992M	35.87%1.02B
Research and development costs	16.43%978M	13.28%273M	19.89%223M	-0.97%205M	34.47%277M	9.66%840M	-17.18%241M	12.73%186M	25.45%207M	42.07%206M
Depreciation and amortization	37.50%99M	0.00%18M	0.00%18M	110.53%40M	35.29%23M	41.18%72M	5.88%18M	38.46%18M	72.73%19M	70.00%17M
-Depreciation	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-Amortization	37.50%99M	0.00%18M	0.00%18M	110.53%40M	35.29%23M	41.18%72M	5.88%18M	38.46%18M	72.73%19M	70.00%17M
Other operating expenses	-2.90%7.57B	-3.87%1.89B	-2.59%1.81B	-0.25%1.99B	-4.91%1.88B	10.57%7.79B	3.80%1.97B	8.23%1.86B	1.58%2B	33.97%1.98B
Operating profit	41.64%5.12B	-6.43%1.85B	-31.31%1.73B	-28.70%934M	127.50%603M	233.83%3.61B	1,234.46%1.98B	328.88%2.52B	186.03%1.31B	-239.06%-2.19B
Net non-operating interest income (expenses)	-29.79%-61M	-63.64%-18M	-23.08%-16M	-18.18%-13M	-16.67%-14M	-95.83%-47M	-57.14%-11M	-160.00%-13M	-10.00%-11M	-500.00%-12M
Non-operating interest income	0.00%1M	--0	0.00%1M	--0	--0	-50.00%1M	--0	--1M	-700.00%-6M	--6M
Non-operating interest expense	29.17%62M	63.64%18M	21.43%17M	160.00%13M	-22.22%14M	84.62%48M	37.50%11M	180.00%14M	-54.55%5M	800.00%18M
Net investment income	-5.88%32M	-58.33%10M	266.67%5M	1,000.00%11M	-50.00%6M	-53.42%34M	20.00%24M	-110.00%-3M	-93.75%1M	71.43%12M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	-90.63%-122M	-140.74%-130M	10M	0	-2M	-6,300.00%-64M	-5,300.00%-54M	0	-10M	0
Income from associates and other participating interests	57.32%-35M	66.67%-7M	-21.74%-28M	103.85%1M	91.67%-1M	-1,740.00%-82M	-200.00%-21M	-483.33%-23M	-620.00%-26M	-1,300.00%-12M
Special income (charges)	-5,150.00%-101M	-101M				-98.74%2M	0
Less:Other special charges	5,150.00%101M	----	----	----	----	97.40%-2M	--0	----	----	----
Other non-operating income (expenses)	133.71%208M	387.80%200M	-157.89%-11M	100.00%6M	-50.00%13M	-31.01%89M	20.59%41M	-53.66%19M	-85.00%3M	-23.53%26M
Income before tax	42.12%5.03B	-8.07%1.8B	-32.21%1.69B	-26.10%937M	127.75%605M	148.91%3.54B	638.87%1.96B	342.80%2.5B	160.37%1.27B	-228.31%-2.18B
Income tax	295.67%1.83B	935.19%451M	17.54%603M	25.97%456M	188.58%318M	-74.29%462M	-115.21%-54M	-37.21%513M	129.11%362M	-176.87%-359M
Net income	4.06%3.21B	-32.99%1.35B	-45.11%1.09B	-46.74%482M	115.71%286M	923.53%3.08B	2,336.67%2.01B	207.43%1.98B	174.24%905M	-247.85%-1.82B
Net income continuous operations	4.09%3.21B	-32.95%1.35B	-45.08%1.09B	-46.91%481M	115.76%287M	923.53%3.08B	2,335.56%2.01B	207.48%1.98B	175.38%906M	-247.81%-1.82B
Noncontrolling interests	0	0	0	0	0	0	0	1M	-1M	0
Net income attributable to the company	4.02%3.21B	-32.99%1.35B	-45.11%1.09B	-46.80%482M	115.71%286M	923.80%3.08B	2,336.67%2.01B	207.43%1.98B	174.55%906M	-247.85%-1.82B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	4.02%3.21B	-32.99%1.35B	-45.11%1.09B	-46.80%482M	115.71%286M	923.80%3.08B	2,336.67%2.01B	207.43%1.98B	174.55%906M	-247.85%-1.82B
Gross dividend payment
Basic earnings per share	5.63%112.71	-31.55%47.71	-44.16%38.32	-46.28%16.74	115.83%9.94	927.77%106.7	2,348.39%69.7	207.81%68.62	173.09%31.16	-247.89%-62.78
Diluted earnings per share	5.63%112.71	-31.55%47.71	-44.16%38.32	-46.28%16.74	115.83%9.94	927.77%106.7	2,347.54%69.7	207.73%68.62	173.09%31.16	-247.96%-62.78
Dividend per share	13.64%25	25.00%15	0	0.00%10	0	10.00%22	20.00%12	0	0.00%10	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data